1. Home
  2. FEMY vs AEON Comparison

FEMY vs AEON Comparison

Compare FEMY & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Femasys Inc.

FEMY

Femasys Inc.

SELL

Current Price

$1.22

Market Cap

11.5M

Sector

Health Care

ML Signal

SELL

Logo AEON Biopharma Inc.

AEON

AEON Biopharma Inc.

HOLD

Current Price

$0.12

Market Cap

13.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FEMY
AEON
Founded
2004
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.5M
13.0M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
FEMY
AEON
Price
$1.22
$0.12
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
★ $14.75
$1.82
AVG Volume (30 Days)
104.8K
★ 809.4K
Earning Date
11-13-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 44.71
N/A
EPS
N/A
★ N/A
Revenue
★ $2,293,313.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$294.61
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 40.77
N/A
52 Week Low
$0.29
$0.11
52 Week High
$6.29
$1.45

Technical Indicators

Market Signals
Indicator
FEMY
AEON
Relative Strength Index (RSI) 36.99 29.39
Support Level $0.33 N/A
Resistance Level $1.55 $0.33
Average True Range (ATR) 0.14 0.03
MACD 0.01 -0.01
Stochastic Oscillator 36.46 10.50

Price Performance

Historical Comparison
FEMY
AEON

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

About AEON AEON Biopharma Inc.

AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.

Share on Social Networks: